Relative incidence of common cancers in people with severe mental illness. Cohort study in the United Kingdom THIN primary care database

Schizophrenia Research

Volumn 143, Issue 1, 2013, Pages 44-49

  Osborn, David P J ^a,b   Limburg, Heather ^d   Walters, Kate ^c   Petersen, Irene ^c,d   King, Michael ^a,b   Green, Jane ^e   Watson, Jo ^e   Nazareth, Irwin ^c,d  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b CAMDEN AND ISLINGTON NHS FOUNDATION TRUST   (United Kingdom)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^d MEDICAL RESEARCH COUNCIL   (United Kingdom)

^e UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Bipolar affective disorder; Cancer; Cohort study; Comorbidity; Primary care; Schizophrenia

Indexed keywords

ADULT; AGED; ARTICLE; BIPOLAR DISORDER; BREAST CANCER; CANCER INCIDENCE; CANCER RISK; COHORT ANALYSIS; COLON CANCER; COLORECTAL CANCER; COMORBIDITY; CONTROLLED STUDY; DATA BASE; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RECTUM CANCER; SCHIZOPHRENIA; UNITED KINGDOM;

ADOLESCENT; ADULT; AGED; BREAST NEOPLASMS; COHORT STUDIES; COLORECTAL NEOPLASMS; FEMALE; GREAT BRITAIN; HUMANS; INCIDENCE; LUNG NEOPLASMS; MALE; MENTAL DISORDERS; MIDDLE AGED; NEOPLASMS; OUTCOME ASSESSMENT (HEALTH CARE); PRIMARY HEALTH CARE; REGRESSION ANALYSIS; YOUNG ADULT;

EID: 84871933374     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2012.11.009     Document Type: Article

References (23)

1. Booth N. What are the read codes?. Health Libr. Rev. 1994, 11(3):177-182.
2. Bourke A., Dattani H., Robinson M. Feasibility study and methodology to create a quality-evaluated database of primary care data. Inform. Prim. Care 2004, 12:171-177.
3. Bushe C.J., Hodgson R. Schizophrenia and cancer. Do we understand the connection?. Can. J. Psychiatry 2010, 55(12):761-767.
4. Chou F., Tsai K., Su C., Lee C. The incidence and relative risk factors for developing cancer among patients with schizophrenia: a nine-year follow-up study. Schizophr. Res. 2011, 129(2-3):97-103.
5. Dave S., Petersen I. Creating medical and drug code lists to identify cases in primary care databases. Pharmacoepidemiol. Drug Saf. 2009, 18(8):704-707.
6. Dembling B.P., Chen D.T., Vachon L. Life expectancy and causes of death in a population treated for serious mental illness. Psychiatr. Serv. 1999, 50(8):1036-1042.
7. Goldacre M., Kurina L., Wotton C., Yeates D., Seagroatt V. Schizophrenia and cancer: an epidemiological study. Brit. J. Psychiatry 2005, 187:334-386.
8. Grinshpoon A., Barchana M., Ponizovsky A., Lipshitz I., Nahon D., Tal O., Weizman A., Levav I. Cancer in schizophrenia: is the risk higher or lower?. Schizophr. Res. 2005, 73(2-3):333-341.
9. Hippisley-Cox J., Vinogradova Y., Coupland C., Parker C. Risk of malignancy in patients with schizophrenia or bipolar disorder: nested case-control study. Arch. Gen. Psychiatry 2007, 64(12):1368-1376.
10. Hippisley-Cox J., Coupland C., Vinogradova Y., Robson J., Brindle P. Performance of the QRisk cardiovascular risk prediction algorithm in an independent UK sample of patients from general practice. A validation study. Heart 2008, 94(1):34-39.
11. Howard L.M., Barley E.A., Davies E., Rigg A., Lempp H., Rose D., Taylor D., Thornicroft G. Cancer diagnosis in people with severe mental illness: practical and ethical issues. Lancet Oncol. 2010, 11(8):797-804.
12. Lawrence D., Jablensky A., Threlfall T., Fuller S.A. Excess cancer mortality in Western Australia psychiatric patients due to higher case fatality rates. Acta Psychiatr. Scand. 2000, 101:382-388.
13. Lewis J.D., Bilker W.B., Weinstein R.B., Strom B.L. The relationship between time since registration and measured incidence rates in the General Practice Research Database. Pharmacoepidemiol. Drug Saf. 2005, 14:443-451.
14. Lichtermann D., Ekelund J., Pukkala E., Tanskanen A., Lönnqvist J. Incidence of cancer among persons with schizophrenia and their relatives. Arch. Gen. Psychiatry 2001, 58(6):573-578.
15. Maguire A., Blak B.T., Thompson M. The importance of defining periods of complete mortality reporting for research using automated data from primary care. Pharmacoepidemiol. Drug Saf. 2009, 18:76-83.
16. Marston L., Carpenter J., Walters K., Morris R., Nazareth I., Petersen I. Issues in multiple imputation of missing data for large general practice clinical databases. Pharmacoepidemiol. Drug Saf. 2010, 19(6):618-626.
17. Nazareth I., King M., Haines A., Rangel L., Myers S. Accuracy of diagnosis of psychosis on general practice computer system. Brit. Med. J. 1993, 307:32-34.
18. Osborn D.P.J. The poor physical health of people with mental illness. West. J. Med. 2001, 175:329-332.
19. Osborn D.P.J., Levy G., Nazareth I., Petersen I., Islam A., King M. Relative risk of cardiovascular and cancer mortality in people with severe mental illness from the United Kingdom's General Practice Research Database. Arch. Gen. Psychiatry 2007, 64:242-249.
20. Osborn D.P.J., Baio G., Walters K., Petersen I., Limburg H., Raine R., Nazareth I. Inequalities in the provision of cardiovascular screening to people with severe mental illnesses in primary care. Cohort study in the United Kingdom THIN Primary Care Database 2000- 2007. Schizophr. Res. 2011, 129(2-3):104-110.
21. Prah P., Petersen I., Nazareth I., Walters K., Osborn D. National changes in oral antipsychotic treatment for people with schizophrenia in primary care between 1998 and 2007 in the United Kingdom. Pharmacoepidemiol. Drug Saf. 2012, 21(2):161-169.
22. Townsend P., Phillimore P., Beattie A. Inequalities in Health in the Northern Region 1986, Northern Regional Health Authority and University of Bristol, Newcastle upon Tyne.
23. Tsuang M.T., Perkins K., Simpson J.C. Physical diseases in schizophrenia and affective disorder. J. Clin. Psychiatry 1983, 44:42-46.